Itovebi

{
  "id": "MLC-T-ONC-004552",
  "term": "Itovebi",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with palbociclib and fulvestrant to treat adults with certain types of hormone-receptor positive, HER2-negative breast cancer that has a mutation (change) in the PIK3CA gene. It is also being studied in the treatment of other types of cancer. Itovebi works by blocking the activity of a protein called PI3K-alpha that signals cancer cells to multiply. It also helps break down mutant versions of this protein found in some cancer cells. This may keep cancer cells from growing and may kill them. Itovebi is a type of targeted therapy drug called an enzyme inhibitor. Also called inavolisib.",
  "synonyms": [
    "inavolisib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/itovebi/"
}